key: cord-0717551-5pzfo3ys
authors: Gubbay, J. B.; Rilkoff, H.; Kristjanson, H. L.; Forbes, J. D.; Murti, M.; Eshaghi, A.; Broukhanski, G.; Corbeil, A.; Fittipaldi, N.; Hopkins, J.; Kristjanson, E.; Kus, J. V.; Macdonald, L.; Majury, A.; Mallo, G. V.; Mazzulli, T.; Melano, R. G.; Olsha, R.; Perusini, S. J.; Tran, V.; Allen, V. G.; Patel, S. N.
title: Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results
date: 2021-03-03
journal: nan
DOI: 10.1101/2021.03.02.21252768
sha: 28991236b9573282662b668c0a21f81a102e9cb1
doc_id: 717551
cord_uid: 5pzfo3ys

Background: Performance characteristics of SARS-CoV-2 nucleic acid detection assays are understudied within contexts of low pre-test probability, including screening asymptomatic persons without epidemiological links to confirmed cases, or asymptomatic surveillance testing. SARS-CoV-2 detection without symptoms may represent resolved infection with persistent RNA shedding, presymptomatic or asymptomatic infection, or a false positive test. This study assessed clinical specificity of SARS-CoV-2 real-time reverse transcription polymerase chain reaction (rRT-PCR) assays by retesting positive specimens from five pre-test probability groups ranging from high to low with an alternate assay. Materials and Methods: A total of 122 rRT-PCR positive specimens collected from unique patients between March and July 2020 were retested using a laboratory-developed nested RT-PCR assay targeting the RNA-dependent RNA polymerase (RdRp) gene followed by Sanger sequencing. Results: Significantly less positive results in the lowest pre-test probability group (facilities with institution-wide screening having [≤]3 positive asymptomatic cases) were reproduced with the nested RdRp gene RT-PCR assay than in all other groups combined (5/32, 15.6% vs 61/90, 68%; p <0.0001), and in each subgroup with higher pre-test probability (individual subgroup range 50.0% to 85.0%). Conclusions: A higher proportion of false-positive test results are likely with lower pre-test probability. Positive SARS-CoV-2 PCR results should be interpreted within the context of patient history, clinical setting, known exposure, and estimated community disease prevalence. Large-scale SARS-CoV-2 screening testing initiatives among low pre-test probability populations should be evaluated thoroughly prior to implementation given the risk of false positives and consequent potential for harm at the individual and population level.

p <0·0001), and in each subgroup with higher pre-test probability (individual subgroup range 57 50·0% to 85·0%). 75 or asymptomatic (patients who never develop symptoms prior to or following testing) 76 infections, or because of false positive laboratory tests. 1 The likelihood of a false positive rRT-77 PCR result increases as pre-test probability of the condition it is designed to detect decreases. 78 Examples of low pre-test probability scenarios include asymptomatic groups with no known 79 exposure to COVID-19 cases, and communities with low prevalence of COVID-19. Further, a 80 positive rRT-PCR result close to the limit of detection (LOD) of an assay has a greater likelihood 81 of being false positive. 2 82 False positive results can be attributable to pre-analytical errors (e.g. specimen contamination 83 or aliquoting errors), analytical errors (e.g. quality assurance failures, reagent contamination, or 84 non-specific assay signal detection), or post-analytical errors (e.g. improper interpretation or 85 transcription of results). As outlined by Cohen and Kessel, false positive results can have 86 unintended consequences on the public health response including outbreak identification and 87 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Ontario is the most populous province in Canada with approximately 14.7 million residents 10 . 101 The first case of COVID-19 in the province was identified in a patient who presented to hospital 102 on January 23, 2020. 11 The first pandemic wave peaked in April and was characterized by a 103 disproportionate impact on congregate settings including residents in long-term care and 104 retirement homes and for some workplaces. 12 During the first wave, policy changes expanded 105 testing to asymptomatic screening programs within long-term care, hospitals, and some 106 workplace settings, irrespective of risk factors or community prevalence. Such widespread 107 testing has brought into focus the interpretation and implications of positive SARS-CoV-2 rRT-108 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

Public Health Ontario (PHO) Laboratory, the Ontario provincial public health and reference 117 laboratory, conducts approximately 25% of SARS-CoV-2 testing for the province. Specimens are 118 submitted from acute care (e.g., hospitals), community, institutional, and occupational settings, 119 as well as from outbreaks. Specimen data were obtained from the PHO laboratory information Interpreting results for specimens tested using the LDT E gene rRT-PCR assay was based on 128 prior validation data, which determined a LOD of 192 copies/ml of primary sample (95% CI 16 129 to 2,392 copies/ml of specimen), corresponding to Ct values between 34·8 and 38·7. Based on 130 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 1 contains a description of the five categories, ordered from 148 highest pre-test probability setting (Group 1) to lowest pre-test probability setting (Group 5). 149 Groups 1-4 were tested throughout the study period (March -June 2020), whereas Group 5 was 150 tested beyond the peak of the first pandemic wave (May -July 2020).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 2 . The LOD determined during validation was similar to that of the E gene rRT-PCR, at 256 169 copies/ml of primary specimen (95% CI 37.92 to 1733 copies/ml). 170 The proportion of specimens detected by the RdRp gene nested PCR assay as well as the 171 median and range of Ct values were determined overall and for each of the five categories. 172 Statistical significance for median Ct value comparison was calculated using Wilcoxon rank-sum 173 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

A significantly higher rate of RdRp gene nested RT-PCR positivity was also found among 210 asymptomatic patients exposed to a probable or confirmed case (Group 3, 66·7% detected), 211 and among asymptomatic persons who were tested in facilities with ≥10 positive cases (Group 212 4, 50% detected), both reflecting higher pre-test probability scenarios than Group 5. 213 It should be noted that lack of detection with the RdRp gene nested PCR assay is not necessarily 214 a false positive E gene rRT-PCR result, and should not be used to definitively infer false 215 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In general, the PPV of COVID-19 PCR assays is excellent among patients with high pre-test 225 probability and approaches 100%. 2 This was previously determined at PHO using Sanger 226 sequencing of amplicons from RT-PCR positive specimens excluding those for which viral copy 227 number was near the LOD of the assay. However, when testing asymptomatic patients with 228 low pre-test probability in low prevalence settings, the PPV is likely to be different. For 229 example, if community prevalence of SARS-CoV-2 is 1% with a rRT-PCR test sensitivity of 80% 230 and specificity of 99%, the PPV of a positive test is only 44·7%. If prevalence were to increase to 231 5% or 10%, then the PPV increases significantly to 80·8% and 89·9%, respectively. Recent 232 serosurveys conducted by PHO using residual convenience specimens found a low adjusted 233 monthly seroprevalence of 1·1% among specimens received in June, July and again in August, 234 2020. 18 This provides further evidence that Ontario overall was a low prevalence setting for 235 SARS-CoV-2 infection during the study period.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. was done at other laboratories or individuals declined testing. To substantiate that the low-251 prevalence institutional settings had no more than three cases, validation was conducted 252 against provincially reported outbreak-related cases associated with these settings within a 253 three week period. It was assumed that if the number of cases identified by the asymptomatic 254 screening program became greater than 3, an outbreak would be declared and any additional 255 cases would be captured as part of the outbreak.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 3, 2021. ; https://doi.org/10.1101/2021.03.02.21252768 doi: medRxiv preprint A further limitation of this study involves changes to government testing guidelines as the 257 pandemic evolved: changes occurred in both the population incidence of COVID-19 as well as 258 guidelines indicating who should be tested during the period of this study, from March to July 259 2020. This may introduce a bias, since persons tested in periods with more cases, or with 260 stricter testing criteria as occurred earlier in the pandemic in Ontario, may have a greater 261 likelihood of infection. 262 Specimens included in this study were stored at -80C for weeks to months prior to conducting 263 the RdRp gene nested RT-PCR. RNA degradation during storage and freeze-thaw is possible, and 264 was more likely to affect specimens that were close to the LOD, resulting in a negative RdRp RT-265 PCR in a specimen that was true rRT-PCR positive at the time of initial testing. Ct-positive specimens due to difficulty in reproducing results near the assay LOD on retesting. 296 Health care providers, public health professionals, policy-makers and the public will benefit 297 from ongoing education to understand that false positive tests will occur when testing 298 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) c Group 3 contains specimens from institutional outbreaks (as well as non-outbreaks), and thus some specimens could also be 385 classified in the "facility 10+ positive category 386 Tested as part of an outbreak or surveillance testing investigation having three or fewer asymptomatic positive tests and no symptomatic positive cases in the Public Health Ontario's laboratory information system CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 3, 2021. ; https://doi.org/10.1101/2021.03.02.21252768 doi: medRxiv preprint 

Ontario Ministry of Health. Toronto, ON: Queen's Printer for Ontario

Ontario Agency for Health Protection and Promotion (Public Health Ontario)

Ct) Values: An Overview of Cycle Threshold Values and their role in 319

ON: Queen's Printer for 320 Ontario

Table 17-10-0005-01 Population estimates on July 1st, by age and sex

Diagnosis and Management of First Case of 341

2020;ciaa227. 342 12. Ontario COVID-19 Data Tool

Detection of 2019 novel coronavirus (2019-nCoV) 346 by real-time RT-PCR

Ontario Ministry of Health. Toronto, 348 ON: Queen's Printer for Ontario

Correlation between 350 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 351 isolates

Assays for laboratory confirmation of novel 354 human coronavirus (hCoV-EMC) infections

Monitoring 360 the COVID-19 epidemic in the context of widespread local transmission

Spread of SARS-CoV-2 in the Icelandic population